Table 1 Data regarding age and sex, number of recurrences, interval elapsed between diagnosis and recurrences, IVIG administration at diagnosis and at recurrence, CAAs at diagnosis and at recurrence
From: Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature
Author ref. Nation (notes) | Num. of pts | Age at first recurrence (months) | Sex | Months between first diagnosis and recurrence | Num. Of recurrences | Num. Of pts receiving IVIG at D | Num. of pts receiving IVIG at recurrence | Num. of pts with CAA at first diagnosis | Num. of pts with CAA at recurrence |
|---|---|---|---|---|---|---|---|---|---|
Guleria et al. [3] India (Case series) | 7 | Mean 36* | M 5# | 8.7 * | 1 | 6 | 5 | 1 | 1 |
F 2# | |||||||||
Goswami et al. [2] USA | 1 | 120 | F | 49 (1th) | 2 | na | 1 | 0 | 1 |
109 (2th) | |||||||||
Verma et al. [4] India | 1 | 96 | F | 48 | 1 | 1 | 1 | Na | 1 |
Kang et al. [27] Korea (Case series) | 25 | Mean 49* | M 16# | 21 (1th) | 1; 22# | 25 | 25 | 5 | 2 |
Na (2th) | 2; 2# | ||||||||
F 9# | |||||||||
Na (3th) | 3; 1# | ||||||||
Saha et al. [13] India | 1 | 96 | M | 24 | 1 | 0 | 1 | 1 | 1 |
Lee et al. [26] Korea (Case series) | 14 | Mean 41* | M 8# | 18* | 1 | Na | Na | Na | Na |
F 6# | |||||||||
Verma et al. [14] India | 1 | 8 | F | 48 | 1 | Na | 1 | Na | Na |
Aldemir Kocabaş et al. [15] Turkey | 1 | 108 | M | 90 | 1 | 1 | 1 | 1 | 0 |
See et al. [16] Singapore | 1 | 48 | M | 30 | 1 | 1 | 1 | 1 | 1 |
Yang et al. [28] China (Case series) | 22 | Mean 30* | M 9# | 12* | 1 | 22 | 22 | 10 | 6 |
F 13# | |||||||||
Osman et al. [17] Sudan | 1 | 72 | M | 64 | 1 | 1 | 1 | 0 | 1 |
Balasubramanian et al. [18] India | 1 | 16 | M | 11 | 1 | 1 | 1 | 0 | 1 |
Zou et al. [24] China (Case series) | 20 | Na | na | 15* | Na | Na | Na | 5 | 8 |
Pemberton et al. [20] UK | 1 | 72 | M | 15 | 1 | 1 | 1 | 0 | 0 |
Matsubara et al. [21] Japan | 1 | 68 | F | 38 | 1 | 0 | 1 | 1 | 1 |
Nakada et al. [19] Japan (Case series) | 5 | Na | Na | Na | 1 | Na | Na | Na | 1 |
Nigro et al. [22] Italy | 1 | 10 | F | 1 | 1 | 0 | 0 | 0 | Na |
Hamada et al. [23] Japan | 1 | 12 | M | 1 (1th) | 3 | 1/1 | 1 | 0 | 0 |
3 (2th) | |||||||||
12 (3th) | |||||||||
Present case Italy | 1 | 29 | M | 9 (1th) | 2 | 1 | 1 | 0 | 0 |
19 (2th) |